The prevalence of anxiety and depression among patients with obstructive ventilation disorders: the Respect study. Part I

封面

如何引用文章

全文:

详细

The article presents an analysis of the prevalence of anxiety and depression in people with obstructive ventilation disorders based on the results of the RESPECT population study (RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related aetiology). The findings indicate a high prevalence of subclinical and clinical anxiety (18.4%) or depression (21.3%) among people with persistent obstructive ventilation disorders. People with such disorders have been inclined to show more severe health problems and a lower self-esteem for their health.

作者简介

Elena Andreeva

Northern State Medical University

编辑信件的主要联系方式.
Email: klmn.69@mail.ru

PhD, associate professor of the Department of Family Medicine

俄罗斯联邦, Arkhangelsk

Marina Pokhaznikova

North-Western State Medical University named after I.I. Mechnikov

Email: marina.pokhaznikova@szgmu.ru

PhD, associate professor of the Department of Family Medicine

俄罗斯联邦, Saint Petersburg

Irina Moiseeva

North-Western State Medical University named after I.I. Mechnikov

Email: irina.moiseeva@szgmu.ru

PhD, associate professor of the Department of Family Medicine

俄罗斯联邦, Saint Petersburg

Olga Kuznetsova

North-Western State Medical University named after I.I. Mechnikov

Email: olga.kuznetsova@szgmu.ru

DSc, professor, Head of the Department of Family Medicine

俄罗斯联邦, Saint Petersburg

J Degryse

Université Catholique de Louvain

Email: jan.degryse@kuleuven.be

MD, PhD, professor

比利时, Brussels

参考

  1. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017. Available from: http://www.goldcopd.org. Последнее посещение сайта 07.09.2017.
  2. The Global Strategy for Asthma Management and Prevention (GINA), Report 2017. Available from: http://ginasthma.org. Последнее посещение сайта 07.09.2017.
  3. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;133:345-349.
  4. Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;(58):858-866.
  5. Cafarella PA, Effing TW, Usmani ZA, et al. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology. 2012;(17):627-638.
  6. Maurer J, Rebbapragada V, Goldstein R, et al. Anxiety and Depression in COPD. Current Understanding, Unanswered Questions, and Research Needs. Chest. 2008;134:43S-56S.
  7. Hanania NA, Müllerova H, Locantore NW, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med.2011;5(183):604-611.
  8. Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010;(137):341-347.
  9. Goodwin RD, Lavoie KL, Lemeshow AR, et al. Depression, anxiety, and COPD: The unexamined role of nicotine dependence. Nicotine & Tobacco Research. 2012;(14):176-183.
  10. Blakemore A, Dickens C, Guthrie E, et al. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2014;9(20):501-512.
  11. Atlantis E, Fahey P, Cochrane BB, Smith S. Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest. 2013;3(144):766-777.
  12. Gao YH, Zhao HS, Zhang FR, et al. The Relationship between Depression and Asthma: A Meta-Analysis of Prospective Studies. PLoS One. 2015;7(10):e0132424.
  13. Han YY, Forno E, Marsland AL, et al. Depression, Asthma, and Bronchodilator Response in a Nationwide Study of US Adults. Allergy Clin Immunol Pract. 2016;1(41):68-73.
  14. Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry. 2003;11(60):1125-1130.
  15. Ryu YJ, Chun E-M, Lee JH, Chang JH. Prevalence of Depression and Anxiety in Outpatients with Chronic Airway Lung Disease. Korean J Intern Med. 2010;1(25):51-57.
  16. Andreeva E, Pokhaznikova M, Lebedev A, et al. The RESPECT study: RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocol. BMC Public Health. 2015. doi: 10.1186/s12889-015-2161-z.
  17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;6(67)6:361-370.
  18. Group EQ. EuroQol – a new facility for the measurement of health – related quality of life. Health Policy. 1990(16):199-208.
  19. EQ-5D [http://www.euroqol.org/about-eq-5d/how-to-use-eq-5d.html].
  20. Bakke PS, Rönmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011;6(38):1261-1277.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Andreeva E.A., Pokhaznikova M.A., Moiseeva I.E., Kuznetsova O.Y., Degryse J.-., 2017

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).